172 related articles for article (PubMed ID: 37543629)
1. Acromegaly with initial negative oral glucose tolerance test: a case report.
Tsai WH; Chien MN; Dai SH; Chan YK
J Med Case Rep; 2023 Aug; 17(1):333. PubMed ID: 37543629
[TBL] [Abstract][Full Text] [Related]
2. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
[TBL] [Abstract][Full Text] [Related]
3. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
5. Delayed diagnosis of acromegaly in a patient with focal segmental Glomerulosclerosis: a rare case report and literature review.
Zheng J; Cui Z; Lv JC; Duan HZ; Wang SX; Zhang JQ; Zhou FD; Guo XH; Zhao MH
BMC Nephrol; 2019 Nov; 20(1):435. PubMed ID: 31771524
[TBL] [Abstract][Full Text] [Related]
6. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
7. Macro-GH - A clinical entity causing a diagnostic challenge - A case report.
Stelmachowska-Banaś M; Ostrowska M; Goszczyński TM; Kowalski K; Korbonits M; Kapuścińska R; Zgliczyński W; Glinicki P
Clin Chim Acta; 2023 Jun; 546():117392. PubMed ID: 37187223
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly with congenital generalized lipodystrophy - two rare insulin resistance conditions in one patient: a case report.
Guerreiro V; Bernardes I; Pereira J; Silva RP; Fernandes S; Carvalho D; Freitas P
J Med Case Rep; 2020 Feb; 14(1):34. PubMed ID: 32079542
[TBL] [Abstract][Full Text] [Related]
9. Caloric restriction as a possible pitfall for persistent acromegaly follow-up - case report.
Martins AF; Santos M; Rosário F
BMC Endocr Disord; 2023 Mar; 23(1):68. PubMed ID: 36973824
[TBL] [Abstract][Full Text] [Related]
10. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
[TBL] [Abstract][Full Text] [Related]
11. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
Rotermund R; Burkhardt T; Rohani Z; Jung R; Aberle J; Flitsch J
Growth Horm IGF Res; 2018 Aug; 41():64-70. PubMed ID: 29555234
[TBL] [Abstract][Full Text] [Related]
12. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
[TBL] [Abstract][Full Text] [Related]
13. Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?
Rosario PW; Calsolari MR
Arch Endocrinol Metab; 2016; 60(6):510-514. PubMed ID: 27982199
[TBL] [Abstract][Full Text] [Related]
14. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
15. Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics.
Attanasio R; Oppizzi G; Lodrini S; Dallabonzana D; Barausse M; Orlandi P; DaRe N; Cozzi R
Eur J Endocrinol; 1999 Jan; 140(1):23-8. PubMed ID: 10037247
[TBL] [Abstract][Full Text] [Related]
16. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
Carmichael JD; Bonert VS; Mirocha JM; Melmed S
J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly resolution after traumatic brain injury: a case report.
Cob A
J Med Case Rep; 2014 Sep; 8():290. PubMed ID: 25182385
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy.
Kinoshita Y; Tominaga A; Usui S; Arita K; Sakoguchi T; Sugiyama K; Kurisu K
Neurosurg Rev; 2016 Apr; 39(2):313-8; discussion 318-9. PubMed ID: 26785642
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
